大规模集会中的脑膜炎球菌病预防:来自朝觐与副朝觐的经验教训
脑膜炎球菌病是严重公共卫生威胁,大规模集会可促进包括脑膜炎奈瑟菌在内的病原体传播。沙特阿拉伯朝觐与副朝觐通过实施疫苗接种、化学预防和健康宣教等综合措施,成功降低了脑膜炎球菌病发病率并控制暴发,其经验可为全球其他大规模集会的预防策略提供参考。
要点
- 大规模集会期间应基于全面风险评估实施脑膜炎球菌病预防措施。
- 预防措施可包括疫苗接种、化学预防和健康宣教,并需高效疾病监测与应对系统支持。
- 朝觐与副朝觐的经验表明综合预防措施可降低发病并控制暴发。
核心结论
- 朝觐与副朝觐实施综合预防措施成功降低了脑膜炎球菌病发病率并控制与预防了暴发,其经验可为全球其他大规模集会的脑膜炎球菌病预防策略提供参考。
研究设计与样本
- 本文为综述,总结沙特阿拉伯朝觐与副朝觐大规模集会中脑膜炎球菌病预防措施的经验与教训。
主要发现
- 脑膜炎球菌病在提供传播条件的大规模集会期间值得关注。
- 朝觐与副朝觐中实施预防措施成功降低了脑膜炎球菌病发病率并控制与预防了暴发。
临床怎么用
- 原文指出,在风险大规模集会期间实施适当的脑膜炎球菌病预防措施对预防疾病和暴发至关重要。
- 原文指出,预防措施应基于对这些活动中疾病的全面风险评估,可包括疫苗接种、化学预防和健康意识与教育运动,并需高效疾病监测与应对系统支持。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Meningococcal disease is a serious public health threat given the seriousness of the illness, its disabling sequelae and its potential for epidemic spread. The disease is a concern during mass gatherings which provide conditions that facilitate transmission of infectious agents including Neisseria meningitidis. Implementation of appropriate meningococcal disease preventive measures during at-risk mass gatherings is crucial to prevent illness and outbreaks which may result in significant morbidity and mortality as well as local and international spread of the disease. These preventive measures should be informed by comprehensive risk assessments of the disease at those events and may include the use of vaccination, chemoprophylaxis and health awareness and educational campaigns, supported by efficient disease surveillance and response systems. The Hajj and Umrah religious mass gatherings in the Kingdom of Saudi Arabia are examples of how the implementation of such preventive measures was successful in reducing the incidence of meningococcal disease during these events as well as controlling and preventing outbreaks. Lessons learned from the Hajj and Umrah experience can inform meningococcal disease preventive strategies for other mass gatherings worldwide.
引用
- Yezli S, Gautret P, Assiri AM, et al. Prevention of meningococcal disease at mass gatherings: Lessons from the Hajj and Umrah. Vaccine. 2018. PMID: 29954630. doi:10.1016/j.vaccine.2018.06.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。